Stock listing
ALTHX Stock Price, News, Filings & Events — Thx Pharma
Selected listing: ALTHX · EURONEXT · EUR · FR
This page tracks Thx Pharma's ALTHX:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALTHX:EURONEXT. ALTHX:EURONEXT is the stock-level entry point for investors researching Thx Pharma, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Thx Pharma, traded under the ticker ALTHX, is a public company based in France with a market capitalization of approximately €61 million. The company focuses on pharmaceutical development and innovation. Thx Pharma is committed to advancing healthcare solutions through its research and product offerings.
- Ticker
- ALTHX:EURONEXT
- Asset type
- Stock
- Market cap
- $56.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- EURONEXT
- Currency
- EUR
Thx Pharma ALTHX:EURONEXT stock context
This page tracks Thx Pharma's ALTHX:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALTHX:EURONEXT. ALTHX:EURONEXT is the stock-level entry point for investors researching Thx Pharma, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Thx Pharma, traded under the ticker ALTHX, is a public company based in France with a market capitalization of approximately €61 million. The company focuses on pharmaceutical development and innovation. Thx Pharma is committed to advancing healthcare solutions through its research and product offerings.
Latest news from Thx Pharma
Thx Pharma : Corrected press release : THX Pharma and the Beyond Batten Disease Foundation Announce the Grant of a European Patent Protec...
September 9, 2026
Thx Pharma : THX Pharma and the Beyond Batten Disease Foundation Announce the Grant of a European Patent Protecting the Use of Batten-1 i...
September 8, 2026
Thx Pharma : THX Pharma, BBDF and Biocodex Announce Regulatory Submissions for the Phase 3 Clinical Trial of Batten-1 in Juvenile Batten ...
September 1, 2026
Thx Pharma : THX Pharma Reports Cash Position as of June 30, 2026
July 9, 2026
Thx Pharma : THX Pharma Announces the Appointment of Sophie Jacq Lapointe to its Board of Directors
June 23, 2026
Research Thx Pharma
Thx Pharma investor report
Review AI stock analysis and investor report context for ALTHX:EURONEXT.
Thx Pharma company profile
View the public company page for Thx Pharma on 6ix.
Thx Pharma news
Read company news and market updates connected to Thx Pharma.
Thx Pharma investor events
Find investor webinars, events, and replay context for Thx Pharma.
Alternate listings
3VG:GETTEX
DE · EUR
Alternate listing for Thx Pharma; the primary context on this page is ALTHX:EURONEXT.
A2H6LX:LSX
DE · EUR
Alternate listing for Thx Pharma; the primary context on this page is ALTHX:EURONEXT.
A2H6LX:LS
DE · EUR
Alternate listing for Thx Pharma; the primary context on this page is ALTHX:EURONEXT.
3VG:FWB
DE · EUR
Alternate listing for Thx Pharma; the primary context on this page is ALTHX:EURONEXT.
3VG:MUN
DE · EUR
Alternate listing for Thx Pharma; the primary context on this page is ALTHX:EURONEXT.
ALTHXP:TURQUOISE
GB · EUR
Alternate listing for Thx Pharma; the primary context on this page is ALTHX:EURONEXT.
3VG:SWB
DE · EUR
Alternate listing for Thx Pharma; the primary context on this page is ALTHX:EURONEXT.